Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007255
Filing Date
2025-05-12
Accepted
2025-05-12 07:39:20
Documents
77
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pmn-20250331x10q.htm   iXBRL 10-Q 1247233
2 EX-10.1 pmn-20250331xex10d1.htm EX-10.1 28410
3 EX-10.3 pmn-20250331xex10d3.htm EX-10.3 38564
4 EX-31.1 pmn-20250331xex31d1.htm EX-31.1 8940
5 EX-31.2 pmn-20250331xex31d2.htm EX-31.2 8830
6 EX-32.1 pmn-20250331xex32d1.htm EX-32.1 10626
7 GRAPHIC pmn-20250331xex10d1001.jpg GRAPHIC 7786
8 GRAPHIC pmn-20250331xex10d3001.jpg GRAPHIC 4071
  Complete submission text file 0001558370-25-007255.txt   6060830

Data Files

Seq Description Document Type Size
9 EX-101.SCH pmn-20250331.xsd EX-101.SCH 49594
10 EX-101.CAL pmn-20250331_cal.xml EX-101.CAL 32577
11 EX-101.DEF pmn-20250331_def.xml EX-101.DEF 151767
12 EX-101.LAB pmn-20250331_lab.xml EX-101.LAB 382069
13 EX-101.PRE pmn-20250331_pre.xml EX-101.PRE 284328
80 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20250331x10q_htm.xml XML 1035700
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41429 | Film No.: 25932604
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)